ZA201106708B - Tricyclic indole derivatives as pbr ligands - Google Patents
Tricyclic indole derivatives as pbr ligandsInfo
- Publication number
- ZA201106708B ZA201106708B ZA2011/06708A ZA201106708A ZA201106708B ZA 201106708 B ZA201106708 B ZA 201106708B ZA 2011/06708 A ZA2011/06708 A ZA 2011/06708A ZA 201106708 A ZA201106708 A ZA 201106708A ZA 201106708 B ZA201106708 B ZA 201106708B
- Authority
- ZA
- South Africa
- Prior art keywords
- indole derivatives
- tricyclic indole
- pbr ligands
- pbr
- ligands
- Prior art date
Links
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16413109P | 2009-03-27 | 2009-03-27 | |
| GBGB0905328.1A GB0905328D0 (en) | 2009-03-27 | 2009-03-27 | Indole derivatives |
| PCT/EP2010/053998 WO2010109007A2 (en) | 2009-03-27 | 2010-03-26 | Indole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201106708B true ZA201106708B (en) | 2013-02-27 |
Family
ID=40671850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2011/06708A ZA201106708B (en) | 2009-03-27 | 2011-09-13 | Tricyclic indole derivatives as pbr ligands |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8790619B2 (enExample) |
| EP (1) | EP2411362B1 (enExample) |
| JP (1) | JP5651163B2 (enExample) |
| KR (1) | KR101692090B1 (enExample) |
| CN (1) | CN102448933B (enExample) |
| AU (1) | AU2010227527B2 (enExample) |
| BR (1) | BRPI1010261A2 (enExample) |
| CA (1) | CA2756887C (enExample) |
| ES (1) | ES2635310T3 (enExample) |
| GB (1) | GB0905328D0 (enExample) |
| IL (1) | IL215019A0 (enExample) |
| MX (1) | MX2011010154A (enExample) |
| NZ (1) | NZ595227A (enExample) |
| RU (1) | RU2525196C2 (enExample) |
| SG (1) | SG174589A1 (enExample) |
| WO (1) | WO2010109007A2 (enExample) |
| ZA (1) | ZA201106708B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0905328D0 (en) | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
| RU2551423C2 (ru) * | 2010-03-26 | 2015-05-27 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Производные трициклического индола в качестве лигандов pbr |
| GB201016038D0 (en) | 2010-09-24 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method |
| GB201016411D0 (en) * | 2010-09-30 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method for cancer |
| GB201021263D0 (en) | 2010-12-15 | 2011-01-26 | Ge Healthcare Ltd | Solid phase extraction method |
| WO2012138894A1 (en) * | 2011-04-05 | 2012-10-11 | Sloan-Kettering Institute For Cancer Research | Hsp90 inhibitors |
| EP2718464A1 (en) | 2011-06-06 | 2014-04-16 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
| AU2012315757B9 (en) * | 2011-09-30 | 2018-01-25 | Ge Healthcare Limited | Calibration and normalization systems and methods for radiopharmaceutical synthesizers |
| RU2015118217A (ru) * | 2012-11-30 | 2017-01-11 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ кристаллизации трициклических индольных производных |
| KR20150088803A (ko) | 2012-11-30 | 2015-08-03 | 지이 헬쓰케어 리미티드 | 트리시클릭 인돌을 생성하는 아연 할라이드 매개 고리화 방법 |
| GB201312768D0 (en) * | 2013-07-17 | 2013-08-28 | Ge Healthcare Ltd | Work-up procedure |
| GB201316762D0 (en) * | 2013-09-20 | 2013-11-06 | Ge Healthcare Ltd | Novel compounds |
| GB201316764D0 (en) * | 2013-09-20 | 2013-11-06 | Ge Healthcare Ltd | Novel compounds |
| GB201316766D0 (en) * | 2013-09-20 | 2013-11-06 | Ge Healthcare Uk Ltd | Macrophage Imaging |
| KR102458116B1 (ko) | 2014-12-04 | 2022-10-24 | 지이 헬쓰케어 리미티드 | 방사성 약제로부터의 아세트알데히드의 제거 방법 |
| CN106748802B (zh) * | 2016-12-26 | 2018-11-13 | 南京理工大学 | 一种制备含氟仲胺的方法 |
| CN110997068B (zh) * | 2017-05-24 | 2022-12-06 | 宾夕法尼亚大学董事会 | 用于成像和放射疗法的经放射标记的荧光parp抑制剂 |
| US11200669B2 (en) * | 2019-11-19 | 2021-12-14 | Uih America, Inc. | Systems and methods for determining plasma input function used in positron emission tomography imaging |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3939177A (en) * | 1972-11-22 | 1976-02-17 | Sterling Drug Inc. | 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles |
| US3979391A (en) * | 1972-11-22 | 1976-09-07 | Sterling Drug Inc. | 1,2,3,4-Tetrahydrocarbazoles |
| FR2599740B1 (fr) * | 1986-06-05 | 1988-08-12 | Rhone Poulenc Sante | Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant |
| US5270030A (en) * | 1988-12-29 | 1993-12-14 | Bio-Technology General Corp. | Fibrin binding domain polypeptide and method of producing |
| AU1407399A (en) | 1997-11-14 | 1999-06-07 | Eli Lilly And Company | Treatment for alzheimer's disease |
| PT1048651E (pt) * | 1997-12-03 | 2003-09-30 | Taisho Pharmaceutical Co Ltd | Compostos tetraciclicos contendo azoto |
| JPH11228539A (ja) * | 1997-12-03 | 1999-08-24 | Taisho Pharmaceut Co Ltd | 含窒素四環性化合物 |
| AU767009B2 (en) * | 1998-12-11 | 2003-10-30 | Virginia Commonwealth University | Selective 5-HT6 receptor ligands |
| FR2788776B1 (fr) | 1999-01-26 | 2001-02-23 | Synthelabo | Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique |
| GB0115929D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase electrophilic fluorination |
| GB0115927D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase nucleophilic fluorination |
| US7160909B2 (en) | 2001-08-09 | 2007-01-09 | Eli Lilly And Company | Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| JP2005527466A (ja) | 2001-08-09 | 2005-09-15 | イーライ・リリー・アンド・カンパニー | ｓＰＬＡ２インヒビターとしてのシクロヘプトＢインドール誘導体 |
| GB0523506D0 (en) | 2005-11-18 | 2005-12-28 | Hammersmith Imanet Ltd | Novel in vivo imaging compounds |
| GB0905328D0 (en) | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
-
2009
- 2009-03-27 GB GBGB0905328.1A patent/GB0905328D0/en not_active Ceased
-
2010
- 2010-03-26 RU RU2011138850/04A patent/RU2525196C2/ru active
- 2010-03-26 JP JP2012501315A patent/JP5651163B2/ja active Active
- 2010-03-26 SG SG2011070018A patent/SG174589A1/en unknown
- 2010-03-26 BR BRPI1010261A patent/BRPI1010261A2/pt not_active Application Discontinuation
- 2010-03-26 NZ NZ595227A patent/NZ595227A/xx unknown
- 2010-03-26 EP EP10710356.6A patent/EP2411362B1/en active Active
- 2010-03-26 US US13/258,465 patent/US8790619B2/en active Active
- 2010-03-26 ES ES10710356.6T patent/ES2635310T3/es active Active
- 2010-03-26 KR KR1020117025305A patent/KR101692090B1/ko active Active
- 2010-03-26 AU AU2010227527A patent/AU2010227527B2/en active Active
- 2010-03-26 MX MX2011010154A patent/MX2011010154A/es active IP Right Grant
- 2010-03-26 WO PCT/EP2010/053998 patent/WO2010109007A2/en not_active Ceased
- 2010-03-26 CA CA2756887A patent/CA2756887C/en active Active
- 2010-03-26 CN CN201080023868.3A patent/CN102448933B/zh active Active
- 2010-09-13 US US12/880,218 patent/US8501153B2/en active Active
-
2011
- 2011-09-07 IL IL215019A patent/IL215019A0/en not_active IP Right Cessation
- 2011-09-13 ZA ZA2011/06708A patent/ZA201106708B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5651163B2 (ja) | 2015-01-07 |
| IL215019A0 (en) | 2011-11-30 |
| US8501153B2 (en) | 2013-08-06 |
| NZ595227A (en) | 2013-11-29 |
| RU2525196C2 (ru) | 2014-08-10 |
| MX2011010154A (es) | 2011-10-21 |
| WO2010109007A3 (en) | 2010-11-25 |
| KR20110133492A (ko) | 2011-12-12 |
| JP2012521973A (ja) | 2012-09-20 |
| GB0905328D0 (en) | 2009-05-13 |
| AU2010227527B2 (en) | 2015-03-12 |
| EP2411362A2 (en) | 2012-02-01 |
| RU2011138850A (ru) | 2013-05-10 |
| KR101692090B1 (ko) | 2017-01-02 |
| US20120020884A1 (en) | 2012-01-26 |
| CN102448933B (zh) | 2014-07-02 |
| AU2010227527A1 (en) | 2011-10-13 |
| WO2010109007A2 (en) | 2010-09-30 |
| ES2635310T3 (es) | 2017-10-03 |
| CA2756887A1 (en) | 2010-09-30 |
| SG174589A1 (en) | 2011-10-28 |
| US8790619B2 (en) | 2014-07-29 |
| CN102448933A (zh) | 2012-05-09 |
| HK1167393A1 (en) | 2012-11-30 |
| US20110070161A1 (en) | 2011-03-24 |
| CA2756887C (en) | 2018-06-19 |
| BRPI1010261A2 (pt) | 2016-03-22 |
| EP2411362B1 (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201106708B (en) | Tricyclic indole derivatives as pbr ligands | |
| ZA201208447B (en) | Indoles | |
| EP2646020A4 (en) | INDOLES | |
| SG10201706294VA (en) | Novel benzodiazepine derivatives | |
| EP2393359A4 (en) | COMPOUND DIBENZIMIDAZOLE DERIVATIVES | |
| GB0912778D0 (en) | Fused aminodihydro-oxazine derivatives | |
| GB0912777D0 (en) | Fused aminodihydropyrimidone derivatives | |
| IL217956A (en) | Derivatives of n1-sulfonyl-5-fluoropyrimidinone | |
| IL217953A0 (en) | 5-fluoropyrimidinone derivatives | |
| ZA201202641B (en) | Tricyclic pyrazol amine derivatives | |
| ZA201208067B (en) | Tricyclic indole derivatives as pbr ligands | |
| IL207684A0 (en) | Substituted indole derivatives | |
| ZA201105695B (en) | Indole derivatives as anticancer agents | |
| IL219029A0 (en) | Pyrazolopyrimidine derivatives | |
| IL217952A (en) | Derivatives of n1- acyl-5-fluoropyrimidinone | |
| ME01835B (me) | Derivati pirazinooksazepina | |
| IL232502A0 (en) | New Pyrrol History | |
| GB0909441D0 (en) | Novel indole derivatives | |
| GB201217285D0 (en) | Indole derivatives | |
| IL225393A0 (en) | History of Indole | |
| GB201106796D0 (en) | Pyrrole derivatives | |
| GB0918924D0 (en) | Azaindole derivatives | |
| PL119531U1 (pl) | Lampa tylna zespolona | |
| GB0901231D0 (en) | Ligands | |
| HK1187608A (en) | Indole derivatives |